C. De Boeck (Boortmeerbeek, Belgium), L. Dracea (Brasov, Romania)
Predictive factors of lung function decline in adults with cystic fibrosis
L. Boyer, P. Scheid, F. Alla, S. Montcouquiol, Y. Martinet, F. Chabot (Nancy, France)
|  |
Comparison of progression in lung structure and lung function in children and adolescents with cystic fibrosis
E. Hatziagorou, A. Oikonomou, F. Kirvassilis, M. Mantatzis, P. Prassopoulos, J. Tsanakas (Thessaloniki, Alexandroupolis, Greece)
| |
Comparison in outcome between two CF centers: wWhat makes the difference?
D. Wilschut, A. Ott, A. Lindblad, P. A. de Jong, H. A. Tiddens (Rotterdam, Netherlands; Gothenburg, Sweden)
| |
Prevalence of pseudomonas aeruginosa in pancreatic sufficient CF patients in Scandinavia
A. Lindblad, G. Fluge, L. Hjelte, M. Johannesson, P. K. Knudsen, L. Mared, H. Veber Olesen, T. Pressler, N. Hoiby (Gothenburg, Stockholm, Uppsala, Lund, Sweden; Bergen, Oslo, Norway; Aarhus, Copenhagen, Openhagen, Denmark)
| |
Nocturnal saturation in children with cystic fibrosois
L. J. van der Giessen, M. Bakker, W. C. J. Hop, H. A. W. M. Tiddens (Rotterdam, Netherlands)
| |
Usefulness of impulse oscillometry, single breath diffusion and bodypletysmography for lung function assessment in patients with cystic fibrosis
A. Minarowska, M. Kaczmarski, L. Minarowski, J. Sienkiewicz, M. Mrugacz (Bialystok, Poland)
| |
Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis
M. V. Velasco, A. Aguirre-Jaime, N. Shotola, J. W. Treseler, D. A. Waltz, A. A. Colin (Tenerife, Spain; Boston, United States Of America)
| |
Influence of salivary nitrite on levels in exhaled breath condensate in patients with cystic fibrosis
K. Alving, H. Marteus, P. Kalm-Stephens, E. Näs, L. Nordvall, M. Johannesson (Stockholm, Uppsala, Sweden)
| |
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation
L. Fila, J. Musil, J. Chladek (Prague, Hradec Kralove, Czech Republic)
| |
Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients
L. L. Dracea, E. Buta (Brasov, Romania)
| |
Inspiratory muscle training (IMT) in cystic fibrosis adults
E. Amelina, A. Cherniak, S. Chikina, S. Krasovsky, A. Appaeva (Moscow, Russian Federation)
| |
Improved pulmonary function and increased sputum expectoration in CF patients after additional training with SpiroTiger® compared to supervised conventional physiotherapy alone
M. Pause, W. E. Kamin (Mainz, Germany)
| |
CF diagnosis in adulthood: a greater prevalence of classical forms than expected?
R. Padoan, B. M. Assael, R. Casciaro, V. De Rose, M. Furnari, G. Pisi, G. Pizzamiglio, S. Quattrucci, V. Raia, L. Viviani, A. Bossi (Brescia, Verona, Genova, Orbassano, Palermo, Parma, Milano, Roma, Napoli, Italy)
| |
CFTR gene mutations detected in Japanese individuals with cystic fibrosis
K. Yoshimura, C. Anzai, A. Miyamoto, S. Sakamoto, H. Takaya, M. Kawabata, K. Kishi, E. Tsuboi, Y. Eto (Tokyo, Japan)
| |
Difficulty in diagnosis of patients who have cystic fibrosis like symptoms and borderline sweat test
E. Cakir, Z. S. Uyan, S. Oktem, R. Ersu, B. Karadag, F. Karakoc, E. Dagli (Istanbul, Turkey)
| |
Cystic fibrosis patients with ΔF508 mutation demonstrate local immune response of Th2 type
G. V. Shmarina, A. L. Pukhalsky, D. A. Pukhalskaya, N. V. Petrova, N. I. Kapranov (Moscow, Russian Federation)
| |
Polymorphisms of the IL-10 gene and pseudomonas aeruginosa infection in patients with cystic fibrosis
R. Tesse, F. Cardinale, A. Dellino, T. Tronci, F. Di Domenico, F. Cristofori, O. Sillecchia, F. De Robertis, A. Manca, L. Armenio (Bari, Italy)
| |
How much genotype influences cystic fibrosis associated liver disease?
I. M. Popa, I. Popa, L. Pop, Z. Popa, S. Turcu (Timisoara, Romania)
| |